Astria Therapeutics, Inc.
ATXS
$7.49
-$0.04-0.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -33.05M | -33.71M | -25.63M | -24.53M | -24.17M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.87M | 3.09M | 2.32M | 2.05M | 1.89M |
| Change in Net Operating Assets | -6.87M | -3.40M | 5.94M | -5.48M | 5.49M |
| Cash from Operations | -36.06M | -34.02M | -17.36M | -27.97M | -16.79M |
| Capital Expenditure | -590.00K | -- | 0.00 | -20.00K | -305.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.58M | 28.58M | -3.72M | 6.21M | -67.80M |
| Cash from Investing | 57.99M | 28.58M | -3.72M | 6.19M | -68.10M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 15.30M | 94.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 15.30M | 94.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.93M | -5.44M | -21.08M | -6.48M | -84.80M |